Related Experiment Video
Updated: Jul 14, 2026
09:12
A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
Published on: April 27, 2019
Natriuretic peptides and heart transplant
Luis Almenar1, Luis Martínez-Dolz, Jose Moro
1Unit of Heart Failure and Transplant, Department of Cardiology, Hospital Universitario La Fe, 46015 Valencia, Spain. lu.almenarb5@comv.es
Current Opinion in Molecular Therapeutics
|July 5, 2007
Summary
Natriuretic peptides, hormones secreted by the heart, show potential in managing heart failure. Their role in heart transplant outcomes, however, requires further investigation for clarity.
Area of Science:
- Cardiology
- Endocrinology
- Transplantation Science
Background:
- The heart secretes natriuretic peptides with diuretic, natriuretic, and vasodilating properties.
- Elevated natriuretic peptide levels correlate with ventricular dysfunction, morbidity, and mortality in heart failure.
- Limited research exists on natriuretic peptides in heart transplant recipients.
Purpose of the Study:
- To explore the role of natriuretic peptides in heart transplant outcomes.
- To investigate the significance of increased natriuretic peptide levels during graft dysfunction.
- To clarify the involvement of these peptides in acute rejection and prognosis.
Main Methods:
- Observational study design.
- Measurement of natriuretic peptide levels in heart transplant patients.
- Correlation analysis with clinical outcomes, including graft dysfunction and acute rejection.
Main Results:
- Increased natriuretic peptide levels are observed in cases of heart transplant graft dysfunction.
- The specific role of natriuretic peptides in acute rejection remains unclear.
- Their independent prognostic value in heart transplant patients has not been established.
Conclusions:
- Natriuretic peptides are implicated in heart transplant graft dysfunction.
- Further research is needed to elucidate their role in acute rejection and long-term prognosis after heart transplantation.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...